A Report In Response To The Executive Order On Lowering Prescription Drug Costs For Americans
On January 31, 2023, the U.S. Department of Health & Human Services (HHS) published this report in reponse to the Executive Order (EO) on lowering prescription drug costs for Americans. This report in response to the EO describes three models the Secretary of Health and Human Services (HHS) has selected for testing by the Innovation Center that will complement the prescription drug provisions contained in the Inflation Reduction Act of 2022 (IRA . . .